SRGN and nasopharyngeal carcinoma: Increased expression of serglycin in patients with hepatocellular and nasopharyngeal carcinoma was correlated with unfavorable prognosis and represented an independent unfavorable prognostic indicator for overall survival and recurrence as well as disease free and distant metastasis free survival (30, 103).